Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis
Clinical trial NCT06785974 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06785974
- Sponsor
- Erasmus Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2027-02-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.